Tempus AI TEM Revenue Breakdown

NASDAQ TEM
$76.05 +5.62 (+7.98%)
At close: Nov 6, 2026 · 4:00 PM EST
Annual revenue breakdowns for Tempus AI, fiscal 2022 to 2025, as reported in its filings.
Annual history

Tempus AI Revenue by Product & Service

Years FY 2022–2025
Lines 5
FY 2025 Total $1.27B

Clinical Order was Tempus AI’s largest product and service line in fiscal 2025, bringing in $884.50M of $1.27B (70%).

Tempus AI revenue by product and service, fiscal 2022 to 2025
Product and Service FY 2022 FY 2023 FY 2024 FY 2025
Clinical Order — $328.40M $409.40M $884.50M
Insights Product — $117.60M $186.80M $257.70M
Genomics Product $198.00M $34.60M $42.30M $70.90M
Trials Product — $45.60M $42.40M $38.50M
Ai Applications — $5.10M $12.30M $20.10M
Total $320.70M $531.30M $693.20M $1.27B
Totals include 1 discontinued line from earlier reporting.

Tempus AI revenue by product and service: what the figures show

Tempus AI brought in $1.27B from its five product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 83.5% from $693.20M in fiscal 2024. Clinical Order was the largest at $884.50M (69.6%), ahead of Insights Product at $257.70M (20.3%) and Genomics Product at $70.90M (5.6%). The other two lines brought in $58.60M combined.

Compared with fiscal 2024, Clinical Order grew fastest, up 116.0% to $884.50M, while Trials Product fell the most, down 9.2% to $38.50M.

Tempus AI began breaking out Clinical Order in fiscal 2023, Insights Product in fiscal 2023, Trials Product in fiscal 2023 and Ai Applications in fiscal 2023. Tempus AI stopped reporting Data & Services as a separate line after fiscal 2022, when it brought in $122.70M.

Questions

Tempus AI Revenue Breakdown FAQ

How does Tempus AI make money?

Tempus AI (TEM) reports its revenue by product and service. In fiscal 2025, Clinical Order was its largest product and service line, bringing in $884.50M (69.6% of the total), followed by Insights Product at $257.70M (20.3%).

What is Tempus AI's largest product and service line?

Clinical Order was Tempus AI's largest product and service line in fiscal 2025, bringing in $884.50M, or 69.6% of the $1.27B total across its five product and service lines.

Which Tempus AI product and service line is growing the fastest?

Among Tempus AI's product and service lines that make up at least 2% of revenue, Clinical Order grew fastest in fiscal 2025, up 116.0% from $409.40M to $884.50M.

Where does this revenue breakdown data come from?

Every figure comes from Tempus AI's annual financial filings, as reported. Each line keeps the name Tempus AI gives it, and years follow its fiscal calendar.

How far back does Tempus AI's revenue breakdown go?

Tempus AI's revenue by product and service goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.